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Abstract
Background: Maternal administration of  corticosteroids is essential to improve fetal lung surfactant production and hasten the 
fetal lung maturity in women at risk for preterm birth.
Objectives: The current study aims to evaluate the effects of  dexamethasone on fetal and uteroplacental circulation in pregnan-
cies at risk for preterm birth after 24 hours of  its administration.
Methods: A prospective cross-sectional study was carried out in a tertiary University Hospital and included 52 pregnant women 
with singleton pregnancies. Doppler studies were performed on maternal uterine arteries, umbilical artery, fetal middle cerebral 
artery (MCA) and fetal descending aorta and just before dexamethasone administration and repeated 24 hours after completion 
of  the course.
Results: There was a statistically significant difference between all Doppler indices in the umbilical artery (PI= 1.09±0.4 and 
1.05±0.39, RI= 0.66±0.14 and 0.63±0.14; p=0.001), fetal MCA (RI= 0.86±0.12 and 0.83±0.13, PI= 2.19±0.72 and 2.15±0.72; 
p=0.001) and aorta (RI= 0.9±0.55 and 0.87±0.55; p=0.001, PI= 1.91±0.44 and 1.89±0.44; p=0.040) in comparison before and 
24 hours after maternal dexamethasone administration respectively. Also uterine artery PI was significantly different (0.9±0.27 
and 0.87±0.26; p=0.001).
Conclusion: Antenatal dexamethasone for women at risk of  preterm birth improves the fetal and uteroplacental blood flow at 
24 hours after its administration.
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Introduction
Respiratory distress syndrome (RDS) is one of  the major 
causes of  early neonatal morbidity and mortality especial-
ly in developing countries1. Antenatal administration of  
corticosteroids for women at risk for preterm birth is the 
main line to improve fetal lung surfactant production and 
enhance the fetal lung maturity2. Besides that, they reduce 
the incidence of  intraventricular hemorrhage, necrotizing 
enterocolitis and overall neonatal mortality in preterm in-
fants3.
Dexamethasone is generally safe during pregnancy. Unlike 
betamethasone, some studies reported reduction in fetal 
body movements, fetal breathing movements and heart 
rate variation after administration4,5. Repeated courses 
of  steroids have been associated with increased risk of  
fetal growth restriction6. Therefore, assessment of  fetal 
hemodynamic status after corticosteroid administration 
by Doppler is essential.
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Previous studies showed conflicting results regarding this 
important subject and most of  them were focusing on 
the effect of  steroids on pregnancies complicated with 
intrauterine growth restriction (IUGR)7-9. Also, most of  
previous studies investigated the effect of  betamethasone 
on fetal and uteroplacental blood flow4,5,10,11, few studies 
only investigated the effect of  dexamethasone12.
Therefore, the present study aims to investigate the ef-
fects of  dexamethasone on fetal and uteroplacental circu-
lation in pregnant women at risk for preterm birth after 
24 hours of  its administration.
 
Methods
Study setting and design
The current study was a prospective cross-sectional study 
carried out in a tertiary University Hospital in Egypt 
between January to December 2014. The study was ap-
proved by the institutional Ethical Review Board and 
written consent obtained from all study participants.
Study participants
Eligible participants were pregnant women with gesta-
tional age from 24 to 34 weeks and at risk for preterm 
birth. Gestational age was calculated according to the 
date of  the last menstrual period and confirmed by first 
trimester ultrasound. Patients at risk of  preterm labor in-
cluded were those with preterm uterine contractions, pla-
centa previa, and pre-eclampsia. Meanwhile, Patients who 
were actively in labor, presented with premature rupture 
of  membranes, intrauterine growth restriction (IUGR), 
those who had received corticosteroids in their pregnan-
cies and/or fetuses with suspected structural abnormal-
ities were excluded from participation. Women who had 
any contraindication of  corticosteroids administration 
had also been excluded.
Study intervention
Eligible participants were evaluated through full history 
taking and detailed anatomical scan by level II sonogra-
pher before inclusion to confirm their gestational age and 
exclude any structural anomalies.
Each woman received the recommended course of  corti-
costeroids to induce fetal lung maturity consisting of  two 
doses of  12 mg dexamethasone (Dexamethazone 8 ml, 
Sigma Pharam, Egypt) intramuscularly 12 hours apart.
Doppler studies were performed just before dexametha-
sone administration and repeated 24 hours after comple-
tion of  the dexamethasone course using a SonoAce X6 
machine (Medison, Korea) with 3.75 MHz transabdom-
inal probe. All patients underwent Doppler examination 
by 2 different level II sonographers.
Doppler examination was done with the fetus in a quiet 
state, in absent of  fetal movements and fetal breathing 
movements. The angle of  insonation was optimized to be 
as low as possible, never exceeding 45◦. The sweep speed 
was 2.5 cm /s and the pulse repetition frequency ranged 
from 3.5 - 5.5 Khz. The Doppler spectrum was recorded 
during maternal voluntary apnea.
Blood flow velocity waveforms were obtained from the 
umbilical artery, fetal middle cerebral artery (MCA), fetal 
descending aorta and maternal uterine arteries. Spectral 
pulsed wave Doppler analysis was done after that; RI and 
PI were calculated for each vessel. The formulas used for 
PI and RI were PI = (S-D)/mean and RI = (S-D)/S re-
spectively, when S is the peak Doppler frequency shift 
and D is the minimum. At least 5 uniform waves forms 
of  the spectrum were recorded and analyzed.
Blood flow velocity waveforms were recorded from the 
umbilical artery in the free floating mid-portion of  the 
umbilical cord13. Doppler signals registered from the fetal 
MCA in its proximal third. The MCA vessels were locat-
ed with color Doppler ultrasound overlying the anterior 
wing of  the sphenoid bone near the base of  the skull14.
Doppler signals obtained from the uterine arteries in the 
region of  the lower uterine segment. Insonation of  the 
uterine artery was done at its crossover the iliac artery15. 
Velocity waveforms from the fetal descending aorta were 
recorded at the lower thoracic level just above the dia-
phragm, keeping the angle of  insonation of  the Doppler 
beam below 45°.
The primary outcome of  the study was detection of  
changes in Doppler indices before and after dexametha-
sone administration.
Statistical analysis
Analysis of  data was done using SPSS Inc., (Statistical 
Program for Social Science Inc.,) Chicago, IL, USA, ver-
sion 22. Qualitative variables were expressed as frequency 
and percentage. Quantitative variables were expressed in 
terms of, mean, standard deviation and range. For quan-
titative data, comparison between the Doppler results in 
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the same group was done using paired t-test. Level of  sig-
nificance "P" value was evaluated, where P value < 0.05 
was considered statistically significant.
 
Results
The study included 52 participants at risk of  preterm 
birth. We anticipated the risk of  preterm birth on the 
basis of; preterm uterine contractions (n=33), placenta 
previa (n=13) and pre-eclampsia (n=6)
The demographic data are presented in Table 1. The 
mean age of  the study group was 27.7±4.5 years. At the 
time of  dexamethasone administration, mean gestational 
age was 30.9±2.7 weeks, and in 17 (32.7%) pregnancies, 
gestational age was <30 weeks.
Table 1. Maternal and neonatal characteristics of the study participants. 
 
 Maternal characteristics 
Age (years); mean ±SD 27.7 ± 4.5 
Parity; median (Range) 4 (0 – 7) 
Gestational age (weeks+days)   
At examination; mean ± SD (Range) 30.7 ± 2.5 (24+1 to 33+5) 
At delivery; mean ± SD (Range) 31.1 ± 2.6 (24+4 to 36+3) 
Neonatal characteristics  
Birth weight (gm); mean ± SD 1135.3 ± 750.22   
Referral to PCU; n (%) 30 (57.7) 
1 minute Apgar score < 7; n (%) 35 (67.3) 
5 minutes Apgar score < 7; n (%) 21 (40.4) 
Female gender; n (%) 34 (65.4) 
              PCU; pediatric care unit 
  
Twenty-three (44.2%) of  the study participants delivered 
within 4 days after receiving the full dose of  dexameth-
asone. Eleven (21.2%) women delivered after 5–7 days, 
nine (17.3%) women delivered between 8-15 days and fi-
nally seven (13.5%) women continued pregnancy more 
than 2 weeks after end of  the course. Cesarean sections 
were performed in 35 (67.3%) patients. Only one still-
birth was delivered vaginally due to placental abruption 
in association with pre-eclampsia.
Table 2 shows the results of  Doppler indices in different 
sub-groups of  the study participants.
Overall, there was a statistically significant difference 
between all Doppler indices in umbilical artery (PI= 
1.09±0.4 and 1.05±0.39, RI= 0.66±0.14 and 0.63±0.14; 
p=0.001), fetal MCA (RI= 0.86±0.12 and 0.83±0.13, 
PI= 2.19±0.72 and 2.15±0.72; p=0.001) and aorta (RI= 
0.9±0.55 and 0.87±0.55; p=0.001, PI= 1.91±0.44 and 
1.89±0.44; p=0.040) in comparison before and 24 hours 
after maternal dexamethasone administration respec-
tively. Also uterine artery PI was significantly different 
(0.9±0.27 and 0.87±0.26; p=0.001), while no significant 
difference in uterine artery RI
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Table 2. Fetal and uteroplacental Doppler indices before and 24 hours after dexamethasone administration in the different groups. 
 
  Threatened preterm labor (n=33) Preeclampsia (n=13) Placenta previa (n=6) 
  
Doppler indices Before Dexamethasone 24 hours after Dexamethasone   Before Dexamethasone 
  
  
Mean ± SD 
24 hours after Dexamethasone Before 
Dexamethasone 
24 hours after 
Dexamethasone p-value 
  
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD   
Umbilical artery 
PI 1.04 ± 0.4 1.01 ± 0.21 1.11 ± 0.36 1.06 ± 0.42 1.09 ± 0.26 1.03 ± 0.33 0.001 
Umbilical artery 
RI 0.67 ± 0.19 0.63 ± 0.17 0.69 ± 0.21 0.65 ± 0.17 0.64 ± 0.13 0.62 ± 0.14 0.001 
Fetal aorta PI 1.92 ± 0.6 1.89 ± 0.31 1.91 ± 0.35 1.87 ± 0.43 1.90 ± 0.46 1.88 ± 0.32 0.040 
Fetal aorta RI 0.9 ± 0.51 0.88 ± 0.46 0.92 ± 0.5 0.86 ± 0.11 0.91 ± 0.55 0.88 ± 0.44 0.001 
Fetal MCA PI 2.18 ± 0.56 2.15 ± 0.12 2.19 ± 0.3 2.16 ± 0.55 2.19 ± 0.1 2.15 ± 0.31 0.001 
Fetal MCA RI 0.87 ± 0.33 0.84 ± 0.57 0.86 ± 0.25 0.83 ± 0.3 0.85 ± 0.70 0.83 ± 0.66 0.001 
Uterine artery PI 0.91 ± 0.29 0.88 ± 0.54 0.9 ± 0.13 0.87 ± 0.2 0.89 ± 0.27 0.87 ± 0.21 0.001 
Uterine artery RI 0.58 ± 0.21 0.57 ± 0.11 0.56 ± 0.11 0.54 ± 0.78 0.57 ± 0.34 0.54 ± 0.23 0.147 
        MCA; middle cerebral artery, PA; pulsatility index, RI; resistance index. 
Discussion
In this study, dexamethasone administration was found 
to have a beneficial effect on fetuses at risk for preterm 
birth as evident by the decrease in the Doppler indices of  
umbilical artery, fetal descending aorta, MCA and uterine 
artery.
Umbilical artery Doppler indices showed statistically sig-
nificant reduction 24 hours after dexamethasone adminis-
tration. Our results agreed with Wallace and Baker’s study 
that reported an association between betamethasone 
treatment and decreased placental vascular resistance as 
reflected by waveforms obtained from umbilical artery16. 
This is similarly agreed by Nozaki et al who found a re-
duction in the umbilical artery PI within 24 hours follow-
ing antenatal corticosteroid therapy9.
With regard to fetal descending Aorta Doppler indices of  
our study population demonstrated significant reduction 
in the vascular resistance after dexamethasone adminis-
tration. To the best of  our knowledge, the current study 
was the first to describe a decrease in PI and RI of  the de-
scending Aorta 24 hours after antenatal dexamethasone 
administration.
MCA Doppler indices decreased after the treatment. 
These findings are in agreement with the results of  Chi-
trit et al who observed a transient and significant decrease 
in fetal MCA (PI, RI) after maternal dexamethasone ad-
ministration12. However some studies disagree with our 
results as Senat and Ville and Wijnberger et al, but they 
were on growth-restricted preterm fetuses; no effect was 
found from betamethasone on PI in fetal MCA7,8. In the 
latter study, circulation in fetuses was studied for up to 14 
days, indicating that placental insufficiency was probably 
not severe enough to indicate early delivery. Moreover, 
Senat and Ville examined the effect of  steroids on blood 
flow waveforms in IUGR fetuses and found no signifi-
cant changes of  PI, RI values in the different vessels after 
dexamethasone course.
There was statistical significant reduction in the uterine 
artery Doppler indices before and 24 hours after dexa-
methasone administration in the present study. These 
findings are in agreement with data published by Chitrit et 
al who observed similar transient and significant decrease 
in uterine artery PI and RI after maternal dexamethasone 
administration in healthy fetus11. However, Thuring et al 
reported that there was no significant influence of  beta-
methasone therapy on Doppler indices in uterine circu-
lation in pregnancies with imminent preterm delivery16.
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A study on human placentas by Clifton et al showed that 
the mechanism behind dexamethasone-induced vasodila-
tation might be an endothelium independent mechanism, 
as they did not find any involvement of  endothelium-de-
rived products such as prostaglandin I2 and nitric oxide17.
One of  the limitations of  the current study is that umbili-
cal artery PH was not measured after delivery for accurate 
assessment of  neonatal outcome due to low facilities in 
our hospital, so we depended only on Apgar score.
In conclusion, administration of  dexamethasone to preg-
nant women at risk of  preterm birth could improve the 
blood flow in the uterine arteries, fetal MCA, descending 
aorta and umbilical artery 24 hours after its administra-
tion. The valuable effect of  its administration is constant 
regardless of  the gestational age and fetal weight.
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